ASX:PTX   PRESCIENT THERAPEUTICS LIMITED
So this is another clinical stager.... Coming along with PTX100 and PTX200 studied for breast cancer and incombination with citarabine for acute myeloid leukemia. Technically all levels above 0,13 are a buy!
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。